Filters
The RNAi* therapeutic agent lumasiran demonstrated favourable clinical outcomes for primary hyperoxaluria type 1 (PH1) in both paediatric and adult patients, according to the results of the phase III ILLUMINATE-A and ILLUMINATE-B trials presented at PAS 2021.
Updated analyses of the phase III IMvigor130 trial presented at AACR 2021 revealed the overall survival (OS) benefit of atezolizumab for previously untreated locally advanced or metastatic urothelial carcinoma (mUC), be it alone or with platinum/gemcitabine chemotherapy (CT).
Men with low-risk prostate cancer have better other-cause survival than those with higher-risk disease even after controlling for lifestyle characteristics and comorbidities, a study has shown.
A recent study suggests the need for biochemical verification with cotinine or additional questions about other sources of nicotine to accurately identify nonmuscle invasive bladder cancer (NMIBC) patients who have smoking-related exposures.
While surgeons usually induce renal hypothermia during partial nephrectomy, recent evidence from a randomized controlled trial (RCT) suggests that such approach does not preserve kidney function in patients with normal or mildly impaired renal function.
Adopting more pro-inflammatory diets can increase the risk of urinary incontinence among women younger than 65 years, a recent study has found.
Having a healthy lifestyle could reduce the risk of lethal prostate cancer even in men with a high genetic risk for the disease, a recent study showed.
A recent study has shown that expert surgeons are more efficient and focused in their movement during robot-assisted partial nephrectomy. In addition, automated performance metrics during key steps are associated with objective measures of tumour complexity and may predict clinical outcomes.
In the management of hypertension, men with overactive bladder are less likely to achieve blood pressure control than their peers who do not have the urological condition, according to a study.
Many over-the-counter male supplements claim to help improve testosterone or ease erectile dysfunction (ED), but peer-reviewed trial evidence remain sparse, a recent systematic review has found.
